Top Healthcare Companies in USA List by Market Cap as on July-30-2023

Top Healthcare Companies in USA List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in USA Companies by Market Cap. Largest Top Healthcare Companies in USA List by Market Cap as on July-30-2023.
Top Healthcare Companies in USA
Top Healthcare Companies in USA, Biggest Healthcare Companies in USA, Largest Healthcare Companies in USA.

  1. Atara Biotherapeutics

    World Rank (Jan-05-2024)
    25,337
    Market Cap (Jan-05-2024)
    0.046 Billion USD
    World Rank (Jul-30-2023)
    17,991
    Market Cap (Jul-30-2023)
    0.202 Billion USD
    World Rank (Dec-25-2022)
    16,070
    Market Cap (Dec-25-2022)
    0.284 Billion USD
    World Rank (Jan-07-2022)
    7,703
    Market Cap (Jan-07-2022)
    1.41 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Net Income in USD
    -340 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Atara Biotherapeutics is a off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. It is estimated that the annual revenue is currently $36M per year and has 450 Employees as on 2019. The headquarters is in USA.
    Company Website
    ATARA BIOTHERAPEUTICS INC

  2. Epizyme

    World Rank (Jan-05-2024)
    18,152
    World Rank (Jul-30-2023)
    18,152
    World Rank (Dec-25-2022)
    18,152
    World Rank (Jan-07-2022)
    18,152
    Market Cap (Jan-07-2022)
    0.23 Billion USD
    Annual Revenue in USD
    16 Million USD
    Annual Net Income in USD
    -232 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Epizyme is a Treatment for Cancer and other serious diseases through novel epigenetic medicines company. The company pioneering work in epigenetic drug development is led by the advancement of tazemetostat in a number of cancer indications and treatment settings. The headquarters is in USA.
    Company Website
    EPIZYME INC

  3. NGM Biopharmaceuticals

    World Rank (Jan-05-2024)
    21,519
    Market Cap (Jan-05-2024)
    0.098 Billion USD
    World Rank (Jul-30-2023)
    18,338
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    14,007
    Market Cap (Dec-25-2022)
    0.393 Billion USD
    World Rank (Jan-07-2022)
    8,022
    Market Cap (Jan-07-2022)
    1.32 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Net Income in USD
    -120 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    NGM Biopharmaceuticals is a Clinical Stage Biopharmaceutical company. It is focused on harnessing powerful, untapped biology underlying major diseases to develop transformative therapeutics for patients and focus include cardio metabolic, liver, oncologic and ophthalmic diseases. The headquarters is in USA.

    Company Website
    NGM BIOPHARMACEUTICALS

  4. Fibrogen

    World Rank (Jan-05-2024)
    22,635
    Market Cap (Jan-05-2024)
    0.079 Billion USD
    World Rank (Jul-30-2023)
    18,401
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    6,648
    Market Cap (Dec-25-2022)
    1.467 Billion USD
    World Rank (Jan-07-2022)
    8,306
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    235 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    FibroGen is a Biotechnology company. It collaborating on the development and commercialization of roxadustat for the treatment of anemia in territories including Japan, Europe, the Commonwealth of Independent States, the Middle East and South Africa. The headquarters is in USA.
    Company Website
    FIBROGEN INC

  5. Inogen

    World Rank (Jan-05-2024)
    20,362
    Market Cap (Jan-05-2024)
    0.123 Billion USD
    World Rank (Jul-30-2023)
    18,402
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    13,002
    Market Cap (Dec-25-2022)
    0.457 Billion USD
    World Rank (Jan-07-2022)
    11,106
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    358 Million USD
    Annual Net Income in USD
    -6 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Inogen provides Portable Oxygen Concentrators that are designed to offer a self replenishing, unlimited supply of oxygen that is concentrated from the surrounding air and to operate without the need for oxygen tanks or regular oxygen deliveries. It is operating in 46 countries. The headquarters is in USA.
    Company Website
    INOGEN INC

  6. Heron Therapeutics

    World Rank (Jan-05-2024)
    16,547
    Market Cap (Jan-05-2024)
    0.260 Billion USD
    World Rank (Jul-30-2023)
    18,406
    Market Cap (Jul-30-2023)
    0.187 Billion USD
    World Rank (Dec-25-2022)
    15,577
    Market Cap (Dec-25-2022)
    0.306 Billion USD
    World Rank (Jan-07-2022)
    10,044
    Market Cap (Jan-07-2022)
    0.89 Billion USD
    Annual Revenue in USD
    86 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Heron Therapeutics is a Developing and Commercializing Pharmaceutical Products company. The headquarters is in USA.
    Company Website
    HERON THERAPEUTICS INC

  7. Ziopharm Oncology

    World Rank (Jan-05-2024)
    18,417
    World Rank (Jul-30-2023)
    18,417
    World Rank (Dec-25-2022)
    18,417
    World Rank (Jan-07-2022)
    18,417
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ziopharm Oncology is a Biotechnology company. They develop non-viral and cytokine-driven cell and gene therapies to effectively
    Company Website
    ZIOPHARM ONCOLOGY INC

  8. Puma Biotechnology

    World Rank (Jan-05-2024)
    17,684
    Market Cap (Jan-05-2024)
    0.208 Billion USD
    World Rank (Jul-30-2023)
    18,982
    Market Cap (Jul-30-2023)
    0.168 Billion USD
    World Rank (Dec-25-2022)
    18,277
    Market Cap (Dec-25-2022)
    0.191 Billion USD
    World Rank (Jan-07-2022)
    22,160
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    225 Million USD
    Annual Net Income in USD
    -60 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Puma Biotechnology is a Biopharmaceutical company focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use. The company annual revenue is 272.1 million USD and 272 employees as on 2020. The headquarters is in USA.
    Company Website
    PUMA BIOTECHNOLOGY INC

  9. XBiotech

    World Rank (Jan-05-2024)
    20,147
    Market Cap (Jan-05-2024)
    0.129 Billion USD
    World Rank (Jul-30-2023)
    19,456
    Market Cap (Jul-30-2023)
    0.154 Billion USD
    World Rank (Dec-25-2022)
    21,986
    Market Cap (Dec-25-2022)
    0.094 Billion USD
    World Rank (Jan-07-2022)
    15,854
    Market Cap (Jan-07-2022)
    0.34 Billion USD
    Annual Revenue in USD
    44 Million USD
    Annual Net Income in USD
    -11 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Xbiotech is a Clinical Stage Biopharmaceutical company. The company annual revenue is 10.5 million USD. The headquarters is in USA.
    Company Website
    XBIOTECH

  10. Kodiak Sciences

    World Rank (Jan-05-2024)
    19,085
    Market Cap (Jan-05-2024)
    0.160 Billion USD
    World Rank (Jul-30-2023)
    19,561
    Market Cap (Jul-30-2023)
    0.150 Billion USD
    World Rank (Dec-25-2022)
    14,429
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    4,108
    Market Cap (Jan-07-2022)
    3.74 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -266 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

    Company Website
    KODIAK SCIENCES

Share